(Frederick) WF Thielen MSc

All publications (10)

• Article (7)

  • B. Wijnen, W.F. Thielen, S. Konings, T. Feenstra, M. van der Gaag, W. Veling, L. De Haan, H. Ising, M. Hiligsmann, S.M.A.A. Evers, F. Smit & J. Lokkerbol (2019). Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis. Expert review of pharmacoeconomics & outcomes research.
  • W.F. Thielen, N.C. Büyükkaramikli, R. Riemsma, D. Fayter, N. Armstrong, C. Wei, V. Huertas Carrera, K. Misso, G. Worthy, J. Kleijnen & I. Corro Ramos (2018). Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma. Pharmacoeconomics (Print). doi: 10.1007/s40273-018-0740-4 [go to publisher's site]
  • W.F. Thielen, H.M. Blommestein, L.E.M. Oosten, F.G. Calkoen, A.C. Lankester, J. Zwaginga, K. Le Blanc, A. Redondo, F. Sánchez‐Guijo, M. Algeri, F. Locatelli, W.E. Fibbe & C.A. Uyl - de Groot (2018). Second‐line treatment for acute graft‐versus‐host disease with mesenchymal stromal cells: A decision model. European Journal of Haematology, 101 (5), 676-683. doi: 10.1111/ejh.13158 [go to publisher's site]
  • L.E.M. Oosten, M. Chamuleau, W.F. Thielen, L.C. de Wreede, C. Siemes, J.K. Doorduijn, O.S. Smeekes, M. Kersten, L. Hardi, J.W. Baars, A.M.P. Demandt, W. Stevens, G.W. Nijland, C.A. de Uyl-de Groot, P.M. Kluin, D. de Jong & H. Veelken (2018). Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens. Annals of Hematology, 97 (2), 255-266. doi: 10.1007/s00277-017-3167-7 [go to publisher's site]
  • W.F. Thielen, G. van Mastrigt, L.T. Burgers, W.M. Bramer, H.J.M. Majoie, S.M.A.A. Evers & J. Kleijnen (2016). How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3). Expert review of pharmacoeconomics & outcomes research, 16 (6), 1-17. doi: 10.1080/14737167.2016.1246962
  • W.F. Thielen, H.M. Blommestein & C.A. de Uyl-de Groot (2016). Using appropriate methods in cost-effectiveness analyses: the case of allogeneic hematopoietic cell transplantation in sickle cell disease. Biology of Blood and Marrow Transplantation, 22 (11), 2109-2110. doi: 10.1016/j.bbmt.2016.08.022
  • W.F. Thielen, M. Ten Have, R. De Graaf, P. Cuijpers, A. Beekman & S.M.A.A. Evers (2016). Long-term economic consequences of child maltreatment: a population-based study. European Child & Adolescent Psychiatry, 1-9. doi: 10.1007/s00787-016-0850-5

• Part of book - Chapter (2)

  • K. Ruggeri, J.P. Stuhlreyer, J. Immonen, S. Mareva, A.F. Paul, A. Robbiani, W.F. Thielen, A. Gelashvili, F. Cavassini & F. Naru (2018). Policy evaluation. In K. Ruggeri (Ed.), Behavioral Insight for Public Policy: Concepts and Cases (pp. 3). New York: Routledge
  • W.F. Thielen (2016). Entering your heart: how barely tested medical innovations find their way into clinical practice. In M.T. Brancaccio (Ed.), Governance of Health Care Innovation. Excursions into Politics, Science and Citizenship (pp. 19-40). Maastricht: Creative Commons License CC BY-NC

• Award (1)

  • W.F. Thielen (2018). Best Student Poster Presentation. Overig.

Teaching (5)

Present position